Vbi Vaccines, Inc. (NASDAQ:VBIV)

CAPS Rating: 1 out of 5

A holding company whose operating subsidiary, Paulson Investment Company, Inc., is a service brokerage firm engaged in the financial services industry.

VBIV News and Commentary


How do you think VBIV will perform against the market?

Add Stock to CAPS Watchlist

All Players

8 Outperform
30 Underperform

All-Star Players

2 Outperform
26 Underperform

Wall Street

0 Outperform
0 Underperform

Top VBIV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

jed71 (99.40)
Submitted January 19, 2016

Good find by the Joey triplets (they’re multiplying!!). Prior business plans, prior business names, reverse mergers and reverse stock splits. MUCH more than this in the recent 10-Q. Not much else to say, other than this one should be pretty obvious.… More


Recent Community Commentary

Read the most recent pitches from players about VBIV.


Member Avatar LookMomBoogers (91.60) Submitted: 3/15/2018 11:11:55 AM : Outperform Start Price: $3.87 VBIV Score: -28.42

Call it hope for me, I was diagnosed with Glioblastoma this past December, they're working on an immunotherapy cure for a terminal brain cancer. I hope they get it and I'm buying some shares and my Dr team might be reaching out after my rounds of Chemo and radiation to see if they need a relatively young and healthy patient for an additional subject in their trials. Let's hope it works, because it's generally a pretty devastating diagnosis but, I'm an optimist and I want to be one of the ones that beats this bastard!


Member Avatar SaintCroix (99.40) Submitted: 2/13/2018 9:24:07 PM : Outperform Start Price: $3.69 VBIV Score: -29.24

I'm fascinated by Phillip Frost, the biotech billionaire who loves to invest in micro-cap stocks. He and his team have a history of using reverse-mergers to introduce start-ups into the public markets. Presumably they want to avoid all the regulatory crap that goes along with an IPO. Not to mention banks taking a good chunk of your equity. I feel like Frost is one of the good guys. And this company, focused on a Hepatitis B vaccine, just might beat the pants off Glaxo. (The CEO is a former Glaxo guy).



Member Avatar TSIF (99.98) Submitted: 1/19/2016 1:25:04 PM : Underperform Start Price: $2.07 VBIV Score: +12.08

Joey's, vetted by Jed71, vetted by TSIF...

TSIF notes, however that he would not be surprised to see this one bounce to $2.35 - $2.45 soon, but overall, should decay.

ATM, Press releases and conferences.

Suspect they can fool the market for awhile...not gonna ride tis one as low as it deserves...if volume stays up, it may have several cycles ....

Target: TBD


Find the members with the highest scoring picks in VBIV.

Score Leader


whatsthepoint (99.98) Score: +140.23

The Score Leader is the player with the highest score across all their picks in VBIV.

Member Name Member
Call Time
Score Commentary
benedict23 78.63 6/8/2016 Underperform 5Y $4.35 -34.94% +32.18% +67.12 0 Comment
TinyCapsWatch 99.89 8/1/2016 Underperform 5Y $3.85 -26.49% +28.92% +55.41 0 Comment
80brown 99.96 7/29/2016 Underperform 5Y $3.78 -25.13% +29.43% +54.56 0 Comment
panda91 74.64 7/22/2016 Underperform 1Y $3.73 -24.13% +29.29% +53.42 0 Comment
DrDoofenshmirtz 99.47 5/4/2017 Underperform 5Y $4.30 -34.19% +17.37% +51.55 0 Comment
dinasourneil 99.66 8/19/2016 Underperform 5Y $3.60 -21.39% +28.26% +49.65 0 Comment
Reallynow222 97.28 2/6/2017 Underperform 5Y $3.89 -27.25% +22.29% +49.54 0 Comment
foolishfun4me 99.68 12/9/2016 Underperform 5Y $3.57 -20.73% +24.05% +44.78 0 Comment
antigrowth 96.62 1/2/2018 Underperform 5Y $4.28 -33.88% +4.54% +38.42 0 Comment
OttoLutz 96.99 11/1/2016 Underperform 5Y $3.03 -6.60% +31.50% +38.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for VBIV.

Featured Broker Partners